Author:
Othmani Salah,Battikh Riadh,Abdallah Najmeddine Ben
Reference6 articles.
1. In vitro susceptibility of Streptococcus pneumoniae to the d-and l-isomers of ofloxacin: interpretive criteria and quality control limits;Barry;J Antimicrob Chemother,1996
2. Adverse drug reactions of levofloxacin (Tavanic®): result of a French national pharmacovigilance survey [abstract];Guy;Pharmacoepidemiol Drug Saf,2002
3. Tolérance de la lévofloxacine, dossier clinique et données de pharmacovigilance;Carbon;Thérapie,2001
4. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections;Martin;Drug Saf,2001
5. Péfloxacine : bilan et perspectives cliniques;Modai;Rev Med Interne,1986